Biosimilars Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biosimilars market
Biosimilars Market: By Product (Recombinant Glycosated Proteins and Others) Technology (mAbs, Chromatography, Mass Spectroscopy and Others); By Application (Blood & Oncology Diseases, Chronic Diseases and Others); By Geography-Forecast (2016 - 2021)
Report Code : HCR 0060
Updated Date: 04 June, 2018  
15

Copies sold

    Client Rating

1. Biosimilars– Market Overview
2. Executive Summary
3. Biosimilars – Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Top 5 Financials Analysis
4. Biosimilars – Market Forces
   4.1. Market Drivers
      4.1.1. Economic turmoil in Europe driving demand for biosimilars
      4.1.2. 11 biologics to face patent expiration by 2020
      4.1.3. FDA keen on introducing more biosimilars into the market
      4.1.4. Asian companies have taken advantage by introducing low cost biosimilars
   4.2. Market Constraints and Challenges
      4.2.1. Stringent Regulatory Scenario
      4.2.2. Significant Developmental Cost
      4.2.3. Safety and Efficacy poses questions for physician while prescribing biosimilars
   4.3. Attractiveness of the Biosimilars Industry
      4.3.1. Power of Suppliers
      4.3.2. Power of Customers
      4.3.3. Threat of New entrants
      4.3.4. Threat of Substitution
      4.3.5. Degree of Competition
5. Biosimilars Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Biosimilars Market: By Type
   6.1. Recombinant Non-Glycosylated Proteins
   6.2. Recombinant Glycosylated Proteins
   6.3. Recombinant Peptides Others
7. Biosimilars Market – By Technology
   7.1. Monoclonal Antibodies Technology
   7.2. Recombinant DNA Technology
   7.3. Chromatography
   7.4. Nuclear Magnetic Resonance Technology
   7.5. Electrophoresis
   7.6. Mass Spectrometry
   7.7. Western Blotting
   7.8. Bioassay
8. Biosimilars Market – By Application
   8.1. Blood Disorders
   8.2. Oncology Diseases
   8.3. Chronic and Autoimmune Diseases
   8.4. Growth Hormone Deficiency
   8.5. Others
9. Biosimilars Market -Geographic Analysis
   9.1. Americas
      9.1.1. U.S.
      9.1.2. Canada
      9.1.3. Brazil
      9.1.4. Others
   9.2. Europe
      9.2.1. France
      9.2.2. Germany
      9.2.3. U.K.
      9.2.4. Italy
      9.2.5. Spain
      9.2.6. Others
   9.3. APAC
      9.3.1. China
      9.3.2. India
      9.3.3. Japan
      9.3.4. Australia
      9.3.5. Others
   9.4. ROW
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
   11.1. HOSPIRA INC.
   11.2. STADA ARZNEIMITTEL AG
   11.3. NOVARTIS
   11.4. TEVA PHARMACEUTICAL COMPANY
   11.5. DR. REDDY’S LABORATORIES
   11.6. CELLTRION PHARMA
   11.7. BIOCON LIMITED
   11.8. MYLAN N.V.
   11.9. JOHNSON & JOHNSON
   11.10. DONG-A ST.
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll